Oxford BioDynamics Plc (AIM:OBD)
0.3200
+0.0010 (0.31%)
Oct 31, 2025, 5:38 PM GMT+1
Oxford BioDynamics Revenue
Oxford BioDynamics had revenue of 587.00K GBP in the half year ending March 31, 2025, with 166.82% growth. This brings the company's revenue in the last twelve months to 896.00K, up 45.22% year-over-year. In the fiscal year ending September 30, 2024, Oxford BioDynamics had annual revenue of 636.00K with 24.71% growth.
Revenue (ttm)
896.00K
Revenue Growth
+45.22%
P/S Ratio
6.99
Revenue / Employee
20.36K
Employees
51
Market Cap
6.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 636.00K | 126.00K | 24.71% |
| Sep 30, 2023 | 510.00K | 356.00K | 231.17% |
| Sep 30, 2022 | 154.00K | -187.00K | -54.84% |
| Sep 30, 2021 | 341.00K | -115.00K | -25.22% |
| Sep 30, 2020 | 456.00K | -451.00K | -49.72% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Oxford BioDynamics News
- 11 days ago - AIM Market Roundup: Proteome Sciences, Greenroc Strategic Minerals, IQE - The Armchair Trader
- 19 days ago - Oxford BioDynamics has important role in future cancer screening says report - The Armchair Trader
- 25 days ago - AIM Market Roundup: WH Ireland, Bradda Head, Oxford Biodynamics - The Armchair Trader
- 3 months ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader
- 9 months ago - AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy - The Armchair Trader
- 11 months ago - Small Cap Stocks: i-nexus Global, Genip, Oxford Biodynamics - The Armchair Trader
- 11 months ago - Three Quick Facts: Oxford Biodynamics, Entain, Computacenter - The Armchair Trader
- 11 months ago - Small Cap Stocks: Brand Architekts, tinybuild, Quadrise - The Armchair Trader